Global Therapeutic Proteins and Oral Vaccines Market to Surpass US$ 316,684.7 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE–(BUSINESS WIRE)–#FusionProteins–According to Coherent Market Insights, the global therapeutic proteins and oral vaccines market is estimated to be valued at US$ 201,042.7 million in 2020 and is expected to exhibit a CAGR of 6.7% over the forecast period (2020-2027).

Key Trends and Analysis:

The increasing prevalence of cancer diseases is expected to increase the demand for drugs, in turn fueling the therapeutic protein and oral vaccine market growth in the near future. For instance, according to the World Health Organization report 2018, cancer causing infections such as Human Papilloma Virus (HPA) and hepatitis, are responsible for around 25% cancer cases in low and middle income countries such as Algeria, Angola, Botswana, Brazil, China, Gabon, Libya, Mauritius, Namibia, Seychelles, South Africa, and Tunisia.

Moreover, the increasing number of pharmaceutical companies focusing on research and development for the treatment of various diseases such as growth hormone deficiency (GHD) in young children and others, and this is expected to aid in growth of the market over the forecast period. For instance, in October 2019, OPKO Health Inc. and Pfizer Inc. collaboratively announced that the global Phase 3 trial evaluating somatrogon dosed once weekly in pre-pubertal children with growth hormone deficiency (GHD) met its primary endpoint of non-inferiority to daily GENOTROPIN (somatropin) for injection.

Among regions, North America is expected to exhibit higher growth rate, owing to increasing healthcare expenditure, which is expected to aid in growth of the market. For instance, according to the Centers for Medicare & Medicaid Services (CMS), health spending in the U.S. is estimated to grow at an average rate of 5.5% per year during 2018-27 and to reach around US$ 6.0 trillion by 2027.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4396

Key Market Takeaways:

The global therapeutic protein and oral vaccines market is expected to exhibit a CAGR of 6.7% over the forecast period, owing to increasing number of collaborations by players, which is expected to drive growth of the global therapeutic proteins and oral vaccines market. For instance, Batavia Biosciences and Valneva Sweden AB, a Sweden-based subsidiary of Valneva SE, entered into a collaboration agreement to accelerate market-access of a low-cost inactivated polio vaccine (IPV) oral vaccine under support of Global Polio Eradication Initiative (GPEI).

Key players operating in the global therapeutic proteins and oral vaccines market include Abbott Laboratories, Amgen, Inc., Biogen, Inc, Eily, Lilly, and Company, F. Hoffmann-La Roche, Johnson and Johnson, Merck & Co., Novo Nordisk, Pfizer, Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Emergent Biosolutions Inc., TransAlgae, MigVax Ltd, and Lumen Bioscience, Inc.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4396

Market Segmentation:

• Global Therapeutic Proteins and Oral Vaccine Market, By Drug Class :
  • Therapeutic Proteins
    • Growth Factors
    • Fusion Proteins
    • Monoclonal Antibodies
    • Hormones
    • Coagulation Factors
    • Others
  • Oral Vaccines
    • Live Attenuated Vaccine
    • Inactivated Vaccine
    • Recombinant Vaccine
    • Others
• Global Therapeutic Proteins and Oral Vaccine Market, By Application :
  • Oncology
  • Hematology
  • Immunology
  • Endocrinology
  • Infectious Disease
  • Cardiovascular Disease
  • Others
• Global Therapeutic Proteins and Oral Vaccine Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Therapeutic Proteins and Oral Vaccine Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa

Related Market Intelligence Reports:

Oral Vaccines Market, by Vaccine Type (Live Attenuated, Inactive, Recombinant, and Others), by Application (Polio, Tuberculosis, Rabies, Influenza, Cholera, and Others), by End User (Hospitals, Clinics, Government Organizations, and Others), and by Region (North America, Europe, Latin America, Asia Pacific, Africa, and Middle East) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Read more: https://www.coherentmarketinsights.com/ongoing-insight/oral-vaccines-market-3467

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contacts

Mr. Shah

Senior Client Partner – Business Development

Coherent Market Insights

Phone:
US: +1-206-701-6702

UK: +44-020-8133-4027

Japan: +81-050-5539-1737

India: +91-848-285-0837

Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter